1. Home
  2. FUFU vs AKBA Comparison

FUFU vs AKBA Comparison

Compare FUFU & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FUFU
  • AKBA
  • Stock Information
  • Founded
  • FUFU 2020
  • AKBA 2007
  • Country
  • FUFU Singapore
  • AKBA United States
  • Employees
  • FUFU N/A
  • AKBA N/A
  • Industry
  • FUFU
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • FUFU
  • AKBA Health Care
  • Exchange
  • FUFU NYSE
  • AKBA Nasdaq
  • Market Cap
  • FUFU 566.9M
  • AKBA 669.7M
  • IPO Year
  • FUFU N/A
  • AKBA 2014
  • Fundamental
  • Price
  • FUFU $3.46
  • AKBA $3.03
  • Analyst Decision
  • FUFU Strong Buy
  • AKBA Strong Buy
  • Analyst Count
  • FUFU 1
  • AKBA 4
  • Target Price
  • FUFU $7.00
  • AKBA $6.63
  • AVG Volume (30 Days)
  • FUFU 401.4K
  • AKBA 5.0M
  • Earning Date
  • FUFU 06-05-2025
  • AKBA 05-08-2025
  • Dividend Yield
  • FUFU N/A
  • AKBA N/A
  • EPS Growth
  • FUFU 371.66
  • AKBA N/A
  • EPS
  • FUFU 0.33
  • AKBA N/A
  • Revenue
  • FUFU $463,330,000.00
  • AKBA $184,909,000.00
  • Revenue This Year
  • FUFU $5.51
  • AKBA $21.58
  • Revenue Next Year
  • FUFU $62.99
  • AKBA $47.69
  • P/E Ratio
  • FUFU $10.48
  • AKBA N/A
  • Revenue Growth
  • FUFU 63.08
  • AKBA N/A
  • 52 Week Low
  • FUFU $3.00
  • AKBA $0.80
  • 52 Week High
  • FUFU $7.39
  • AKBA $3.14
  • Technical
  • Relative Strength Index (RSI)
  • FUFU 39.95
  • AKBA 71.68
  • Support Level
  • FUFU $3.36
  • AKBA $2.76
  • Resistance Level
  • FUFU $3.70
  • AKBA $3.14
  • Average True Range (ATR)
  • FUFU 0.28
  • AKBA 0.15
  • MACD
  • FUFU -0.00
  • AKBA 0.02
  • Stochastic Oscillator
  • FUFU 12.82
  • AKBA 86.08

About FUFU BITFUFU INC

BitFuFu Inc is a digital asset mining and cloud-mining service provider that fosters a secure, compliant, and transparent blockchain infrastructure. It provides stable and intelligent digital asset mining solutions, including one-stop cloud-mining services and miner hosting services to institutional customers and individual digital assets. The company generates the majority of its revenue from the sale of cloud-mining solutions, followed by Self-mining revenue. Geographically, the company generates revenue from North America, Asia, Europe, and Others.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: